X

Vous n'êtes pas connecté

Articles similaires

EHA 2024: Updated linvoseltamab data showcase continued deepening of responses in patients with heavily pre-treated multiple myeloma

oncologynews.com.au - 25/Jun 02:36

The 14-month median follow-up data from the pivotal Phase 1/2 LINKER-MM1 trial of linvoseltamab in patients with relapsed/refractory (R/R) multiple...

Author aims to inspire at Camp Meeting

royalgazette.com - 29/Jun 08:00

The Bermuda Conference of Seventh-day Adventists is celebrating its 37th annual Camp Meeting. The event started yesterday and runs through to July 6....

Sorry! Image not available at this time

Takeda Presents Late-Breaking Data from Phase 2b Study of Mezagitamab, Demonstrating Potential to Transform Treatment of Primary Immune Thrombocytopenia

financialpost.com - 23/Jun 16:08

Mezagitamab-Treated Patients Showed Rapid and Sustained Increases in Platelet Counts That Persisted 8 Weeks After the Last Dose Through to Week 161...

Sorry! Image not available at this time

China’s photovoltaic & storage exports achieve record growth with more than 40% surge

evwind.es - 01/Jul 17:05

In 2023, China achieved record photovoltaic export volume growth across all subcomponents, driving manufacturing expansion in emerging markets....

Sorry! Image not available at this time

Personality Theory: Freud’s Psychoanalytic Theory

acedessays.com - 01/Jul 15:13

You work as a psychology consultant at a local prison. You have been asked to give a presentation on personality theories to a group of new case...

Sorry! Image not available at this time

Bonang shows off her new Porsche at 37th birthday celebration

kaya959.co.za - 26/Jun 12:39

Katlego Sekhu Beloved South African media personality Bonang Matheba recently celebrated her 37th birthday with an intimate party surrounded by her...

Sorry! Image not available at this time

Lifezone Metals Announces Voting Results from its 2024 Annual General Meeting

financialpost.com - 21/Jun 20:31

DOUGLAS, Isle of Man — Lifezone Metals Limited (NYSE: LZM) announces the results of voting by shareholders at its 2024 Annual General Meeting...

Sorry! Image not available at this time

PTC Therapeutics announces interim results from phase 2 PIVOT─HD study of PTC518 in Huntington's disease patients

pharmabiz.com - 22/Jun 00:00

PTC Therapeutics, Inc, a global biopharmaceutical company focused on the discovery, development and commercialization of clinically differentiated...